Search scope:
排序: Display mode:
Frontiers of Medicine 2022, Volume 16, Issue 5, Pages 667-685 doi: 10.1007/s11684-022-0960-z
Keywords: Akkermansia muciniphila NAFLD NASH steatosis inflammation
Ruiting Han, Junli Ma, Houkai Li
Frontiers of Medicine 2018, Volume 12, Issue 6, Pages 645-657 doi: 10.1007/s11684-018-0645-9
Keywords: gut microbiota NAFLD obesity insulin resistance bile acids probiotic
Mingfei Yao, Lingling Qv, Yanmeng Lu, Baohong Wang, Björn Berglund, Lanjuan Li
Engineering 2021, Volume 7, Issue 5, Pages 679-686 doi: 10.1016/j.eng.2020.01.017
Non-alcoholic fatty liver disease (NAFLD), which has a global prevalence of 20%–33%, has becometreatment has been established so far, making it urgent to find effective strategies for the treatment of NAFLDWith the identification of the significant role played by the gut microbiota in the pathogenesis of NAFLD, studies on probiotics for the prevention and treatment of NAFLD are increasing in number.have also gained attention due to their potential as therapeutic options for the treatment of NAFLD
Keywords: Non-alcoholic fatty liver disease (NAFLD) Gut microbiota Probiotics Next-generation probiotics (NGPs
Title Author Date Type Operation
Role of Akkermansia muciniphila in the development of nonalcoholic fatty liver disease: current knowledge and perspectives
Journal Article
Mechanistic and therapeutic advances in non-alcoholic fatty liver disease by targeting the gut microbiota
Ruiting Han, Junli Ma, Houkai Li
Journal Article